Human rhinovirus (HRV) antibodies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 2, 2014
Grant Date -
Feb 28, 2013
app pub date -
Aug 28, 2012
filing date -
Aug 30, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention provides isolated fully human monoclonal anti-HRV antibodies, as well as method of making and using these antibodies. Anti-HRV antibodies of the invention prevent or treat subjects having HRV-infections, and related diseases, including, but not limited to, the common cold, nasopharyngitis, croup, pneumonia, bronchiolitis, asthma, chronic obstructive pulmonary disease (COPD), sinusitis, bacterial superinfection, and cystic fibrosis.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully